PDS Biotechnology Corp - Common (PDSB)

CUSIP: 70465T107

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common
Shares outstanding
49,594,356
Total 13F shares
7,451,352
Share change
-789,100
Total reported value
$9,901,943
Put/Call ratio
0%
Price per share
$1.33
Number of holders
55
Value change
-$1,043,791
Number of buys
25
Number of sells
19

Security key

70465T107

Report period

Q2 2025

Institutions

55

Top holders

10

Top shareholders of PDSB - PDS Biotechnology Corp - Common (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARMISTICE CAPITAL, LLC
13F
Company
8.9%
4,419,000
$5,258,610 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
3%
1,510,221
$1,797,163 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.98%
488,033
$580,759 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.88%
437,881
$521,194 31 Mar 2025
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.52%
257,200
$306,068 31 Mar 2025
13F
UBS Group AG
13F
Company
0.51%
251,156
$298,876 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.27%
133,333
$158,666 31 Mar 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.19%
92,030
$110,000 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.17%
82,532
$98,213 31 Mar 2025
13F
INSPIRION WEALTH ADVISORS, LLC
13F
Company
0.15%
75,382
$89,705 31 Mar 2025
13F
Iron Gate Global Advisors LLC
13F
Company
0.15%
75,016
$89,269 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.1%
50,625
$60,244 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.06%
29,293
$34,858 31 Mar 2025
13F
Vanguard Personalized Indexing Management, LLC
13F
Company
0.06%
28,523
$33,942 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.05%
26,954
$32,076 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
25,753
$30,646 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.05%
24,900
$30,000 31 Mar 2025
13F
RITHOLTZ WEALTH MANAGEMENT
13F
Company
0.04%
19,659
$23,394 31 Mar 2025
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0.04%
18,800
$22,372 31 Mar 2025
13F
Tempus Wealth Planning, LLC
13F
Company
0.04%
18,800
$22,372 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.04%
18,382
$21,874 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.03%
17,315
$20,605 31 Mar 2025
13F
Wealth Group, Ltd.
13F
Company
0.03%
15,399
$18,000 31 Mar 2025
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0.03%
15,000
$17,850 31 Mar 2025
13F
Marex Group plc
13F
Company
0.03%
14,000
$16,660 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.03%
13,965
$16,618 31 Mar 2025
13F
Sandbox Financial Partners, LLC
13F
Company
0.03%
12,666
$15,073 31 Mar 2025
13F
MERCER GLOBAL ADVISORS INC /ADV
13F
Company
0.03%
12,500
$14,875 31 Mar 2025
13F
BURNS J W & CO INC/NY
13F
Company
0.02%
10,300
$12,257 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
9,361
$11,140 31 Mar 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.02%
7,898
$9,000 31 Mar 2025
13F
Kathleen S. Wright Associates Inc.
13F
Company
0.01%
7,000
$8,330 31 Mar 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
5,329
$6,342 31 Mar 2025
13F
Blue Trust, Inc.
13F
Company
0.01%
4,500
$5,355 31 Mar 2025
13F
CREATIVE FINANCIAL DESIGNS INC /ADV
13F
Company
0.01%
3,000
$3,570 31 Mar 2025
13F
FMR LLC
13F
Company
0.01%
2,778
$3,306 31 Mar 2025
13F
BESSEMER GROUP INC
13F
Company
0%
1,146
$1,000 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
1,138
$1,354 31 Mar 2025
13F
Truvestments Capital LLC
13F
Company
0%
1,111
$1,322 31 Mar 2025
13F
Hughes Financial Services, LLC
13F
Company
0%
764
$825 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
619
$737 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
500
$595 31 Mar 2025
13F
Rise Advisors, LLC
13F
Company
0%
325
$387 31 Mar 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
257
$306 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
106
$126 31 Mar 2025
13F
Caitong International Asset Management Co., Ltd
13F
Company
0%
1
$1 31 Mar 2025
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
1
$1 31 Mar 2025
13F
DeLyle W. Bloomquist
3/4/5
Resigned as a Director on June 17, 2021.
mixed-class rows
804,941
mixed-class rows
$7,813,350 16 Jun 2021
Seth van Voorhees
3/4/5
Chief Financial Officer
class O/S missing
17,647
$172,588 15 Jun 2021
Matthew C. Hill
3/4/5
Chief Financial Officer
class O/S missing
161,200
05 Jan 2023

Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q2 2025

As of 30 Jun 2025, PDS Biotechnology Corp - Common (PDSB) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,451,352 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, UBS Group AG, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, BLAIR WILLIAM & CO/IL, CITADEL ADVISORS LLC, STATE STREET CORP, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 55 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
46
Q2 2025 holders
55
Holder diff
9
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .